News

Search For News


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

1. Smoking ban linked to drop in stillbirths

Smoking ban linked to drop in stillbirths Date: 20/08/2015The number of babies dying shortly after birth has also dropped by almost eight per cent, the study estimates.The findings add to growing evidence that anti-smoking laws have had significant benefits for infant and child health.Researchers looked at information on more than ten million births in England between 1995 and 2011.Their findings suggest that almost 1500 stillbirths and newborn deaths were averted in the first four years af


2. Birth control pills may offer lasting endometrial cancer protection

Birth control pills may offer lasting endometrial cancer protection Date: 21/08/2015Women who use oral contraceptives during their reproductive years may gain long-term protection against endometrial cancer, a review of previous research suggests.Researchers analyzed 36 studies including more than 140,000 women fromaround the world. They found that every five years of taking birth control pills was linked to a 24 percent reduction in the risk for endometrial cancer, even more than three dec


3. Apitope Raises €12 Million in Series B Funding to Progress Treatments

Apitope Raises €12 Million in Series B Funding to Progress Treatments for Autoimmune DiseasesApitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces it has successfully raised €12 million in a Series B financing. The round was led by new investor Wales Life Sciences Fund. Current investors Vesalius Biocapital, LRM, PMV and Wyvern also participated in the round. Existing shareholders include the Wellcome Trus


4. Ingenza’s Proprietary Technology Produces Novel Antimicrobial Peptide

Ingenza’s Proprietary Technology Produces Novel Antimicrobial PeptideIngenza is collaborating with researchers at Plymouth University to develop an efficient, scalable microbial production system for epidermicin, an exciting new antibiotic that rapidly kills methicillin-resistant Staphylococcus aureus (MRSA) and other harmful bacteria. Mathew Upton, Associate Professor in Medical Microbiology at Plymouth University, explained: “Epidermicin is a stable, 51 amino acid peptide originall


5. AstraZeneca Enhances Long-term Growth through Oncology Investment in A

AstraZeneca Enhances Long-term Growth through Oncology Investment in Acerta Pharma17/12/2015AstraZeneca today announced that it has entered into an agreement to invest in a majority equity stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US. The transaction provides AstraZeneca with a potential best-in-class irreversible oral Bruton's tyrosine kinase (BTK) inhibitor, acalabrutinib (ACP-196), currently in Phase III development for B-cell blood cance



Page 8 of 30 ( 148 results in total )
© Catalyst Innovation Portal 2018